Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.

Bicycle Therapeutics plc American Depositary Shares

Bicycle Therapeutics develops precision-guided therapeutics to target solid tumor cancers and other therapeutic applications. The company aims to create impactful medicines to address unaddressed medical needs.

COM:BICYCLETHERAPEUTICS

Bicycle Therapeutics

Last Close

20.26

22/11 21:00

Market Cap

1.42B

Beta: -

Volume Today

284.35K

Avg: -

People Not Available